Literature DB >> 22266888

Genetics of epilepsy.

Massimo Pandolfo1.   

Abstract

Epilepsy is a common and very heterogeneous neurologic disorder. Genetic factors are likely to play a role in most cases, either because the underlying cause of epilepsy is primarily genetic or because genes modulate susceptibility to an epileptogenic insult. Primarily genetic epilepsies include conditions in which altered brain development or neurodegeneration are at the basis of seizures, but also conditions in which the brain is grossly normal, and the main, if not only, clinical feature is epilepsy. These are called idiopathic epilepsies, though this definition may change in the future. A few idiopathic epilepsies are monogenic disorders due to mutations in a variety of genes affecting neuronal excitability, synaptic transmission, or network development. Most cases have a complex etiology that combines predisposing genetic variants with nongenetic factors. Few of these have been identified so far and only in very few affected individuals, consisting mostly of deletions of critical chromosomal regions. Genetic factors also play a role in the response to antiepileptic drugs, affecting both their efficacy and their tolerability. There have been recent advances in discovering such factors, in particular those underlying risk to medication toxicity. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266888     DOI: 10.1055/s-0031-1299789

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Association of Nicotinamide-N-Methyltransferase Gene rs694539 Variant with Epilepsy.

Authors:  Gensay Sazci; Bilgen Sazci; Ali Sazci; Halil Atilla Idrisoglu
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

2.  A probabilistic model to predict clinical phenotypic traits from genome sequencing.

Authors:  Yun-Ching Chen; Christopher Douville; Cheng Wang; Noushin Niknafs; Grace Yeo; Violeta Beleva-Guthrie; Hannah Carter; Peter D Stenson; David N Cooper; Biao Li; Sean Mooney; Rachel Karchin
Journal:  PLoS Comput Biol       Date:  2014-09-04       Impact factor: 4.475

Review 3.  Genomic Discoveries and Personalized Medicine in Neurological Diseases.

Authors:  Li Zhang; Huixiao Hong
Journal:  Pharmaceutics       Date:  2015-12-07       Impact factor: 6.321

4.  Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy.

Authors:  Andrei Surguchov; Irina Surgucheva; Mukut Sharma; Ram Sharma; Vikas Singh
Journal:  Front Neurol       Date:  2017-01-18       Impact factor: 4.003

Review 5.  The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms.

Authors:  Yifan Zhang; Jingwei Xu; Kun Zhang; Wei Yang; Bingjin Li
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 6.  Altered GABAergic Signaling in Brain Disease at Various Stages of Life.

Authors:  Yoo Sung Kim; Bo-Eun Yoon
Journal:  Exp Neurobiol       Date:  2017-05-19       Impact factor: 3.261

Review 7.  GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration.

Authors:  Tomasz Jaworski; Ewa Banach-Kasper; Katarzyna Gralec
Journal:  Neural Plast       Date:  2019-05-02       Impact factor: 3.599

8.  Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities.

Authors:  Yujia Zhang; Weijing Kong; Yang Gao; Xiaoyan Liu; Kai Gao; Han Xie; Ye Wu; Yuehua Zhang; Jingmin Wang; Feng Gao; Xiru Wu; Yuwu Jiang
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  Inhibition of microRNA 128 promotes excitability of cultured cortical neuronal networks.

Authors:  K Melodi McSweeney; Ayal B Gussow; Shelton S Bradrick; Sarah A Dugger; Sahar Gelfman; Quanli Wang; Slavé Petrovski; Wayne N Frankel; Michael J Boland; David B Goldstein
Journal:  Genome Res       Date:  2016-08-11       Impact factor: 9.043

Review 10.  Recent developments on triazole nucleus in anticonvulsant compounds: a review.

Authors:  Ming-Xia Song; Xian-Qing Deng
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.